452
E. Miserazzi et al. / Tetrahedron Letters 52 (2011) 448–452
Olcay Mert, O. Chem. Rev. 2010, 110, 3419–3478; (n) Sugasawa, T.; Toyota, T.;
Sasakura, K.; Hidaka, T. Chem. Pharm. Bull. 1971, 19, 1971.
mediated by Lawesson’s reagent. Although these results are
currently limited to the piperazinone template, preliminary mech-
anistic aspects of such isomerisation have been investigated by
preparing suitable 13C labelled piperazinones. The data obtained
suggest that this rearrangement could go through formation of
an intermediate A-like (Figs. 3 and 4) involving an internal
red-ox process and a possible chemical path has been proposed
in Figure 3 to rationalize the results observed.
5. (a) Pedersen, B. S.; Scheibye, S.; Nilsson, N. H.; Lawesson, S. O. Bull. Soc. Chim.
Belg. 1978, 87, 223–228; (b) Lawesson, S. O. Org. Synth. 1990, 7, 372–375.
6. (a) Cherkasov, R. A.; Kutyrev, G. A.; Pudovik, A. N. Tetrahedron 1985, 41, 2567–
2624; (b) Cava, M. P.; Levinson, M. I. Tetrahedron 1985, 41, 5061–5087; (c)
Brillon, D. Sulfur Rep. 1992, 12, 297–338; (d) Hideaki, O.; Akihiko, I.; Juzo, N.
Tetrahedron Lett. 2004, 45, 1331–1334; (e) Witold, P. Eur. J. Org. Chem. 2005, 70,
2002–2014.
7. (a) Guryn, R. Pol. J. Chem. 1989, 63, 265–271; (b) Boehme, H.; Ahrens, G.; Krack,
W. Liebigs Ann. Chem. 1982, 3, 585–594; (c) Wang, Y.; Liu, Z. Z.; Chen, S. Z. Chin.
Chem. Lett. 2005, 16, 713–715.
8. Typical experimental procedures for thioamides formation:
Acknowledgements
To a solution of the amide 1 (1 g, 5.26 mmol) in toluene (20 ml), Lawesson’s
reagent (2.13 g, 5.26 mmol) was added portionwise.
We are grateful Dr. Carla Marchioro and her Analytical Chemis-
try Department in Verona for the experimental collaboration and
in particular to Dr. Ornella Curcuruto for High Resolution Mass
generation and to Dr. Luca Rovatti for the effective LCMS support.
The mixture was heated at 80 °C and the reaction progress was monitored by
LCMS. After 3 h the mixture was evaporated to dryness and then dissolved in
200 ml of dichloromethane.
The organic phase was washed with saturated bicarbonate solution (100 ml),
water (100 ml), dried over sodium sulfate and evaporated. The oily material was
purified by flash chromatography eluting with DCM/MeOH from 100/0 to 95/5)
to give 540 mg of 3 as a brownish solid (Y = 45%).
1-(phenylmethyl)-2-piperazinethione (3).
Supplementary data
1H NMR (400 MHz, DMSO-d6): d (ppm) 2.95–3.02, (s, 2H); 3.25–3.30, (t, 2H);
3.78–3.82 (s, 2H); 5.22–5.27, (s, 2H), 7.25–7.40 (m, 5H).
13C NMR (100 MHz, DMSO-d6): d (ppm) 41.1, 48.2, 55.0, 58.3, 127.0, 127.2,
129.1, 138.5, 199.1.
Supplementary data (key experimental procedures, compound
characterizations and selected NMR spectra) associated with this
article can be found, in the online version, at doi:10.1016/
HRMS calculated for [C11H14N2S]; [M+H]+: m/z 207.0956, found m/z 207.0992.
1-(phenylmethyl)-2-piperazinethione-3-13C (3(13C));
1H NMR (400 MHz, CDCl3): d (ppm) 3.11–3.23 (q, 2H), 3.28–3.40 (t, 2H), 3.90–
4.35 (d, J = 140.13 Hz, 2H), 5.30–5.40 (s, 2H), 7.32–7.41 (m, 5H). 13C NMR
(100 MHz, DMSO-d6): d (ppm) 42.15, 48.74, 55.84, 57.49, 127.38, 127.63, 128.49.
HRMS (ES+) calculated for [13CC10H14N2S] [M+H]+: m/z 208.0990, found m/z
208.0992
References and notes
1-(phenylmethyl)-4-propyl-2-piperazinethione (6);
1. (a) Hua, P.; Jay, P.; Liu, J.; Ursu, S.; Sudom, A.; Yan, X.; Xu, H.; Meininger, D.;
DeGraffenreid, M.; He, X.; Jaen, J. C.; Sun, D.; Labelle, M.; Yamamoto, H.; Shan, B.;
Walker, N. P. C.; Wang, Z. Bioorg. Med. Chem. 2008, 16, 8922–8931; (b) Moulin,
A.; Demange, L.; Berge, G.; Gagne, D.; Ryan, J.; Mousseaux, D.; Heitz, A.;
Perrissoud, D.; Locatelli, V.; Torsello, A.; Galleyrand, J. C.; Fehrentz, J. A.;
Martinez, J. J. Med. Chem. 2007, 50, 5790–5806; (c) Larsen, S. D.; DiPaolo, B. A.
Org. Lett. 2001, 3, 3341–3344.
2. (a) Tominaga, Y.; Kohra, S.; Hosomi, A. Tetrahedron Lett. 1987, 28, 1529–1532;
(b) Pousset, C.; Callens, R.; Marinetti, A.; Larcheveque, M. Synlett 2004, 2766–
2770.
1H NMR (400 MHz, CDCl3): d (ppm) 0.84 (3H, t, J = 7.50 Hz) 1.44 (2H, s) 2.28 (2H,
t, J = 7.50 Hz) 2.63 (2H, t, J = 5.42 Hz) 3.33 (2H, t, J = 5.42 Hz) 3.69 (2H, s) 5.23
(2H, s) 7.16–7.32 (5H, m).
HRMS calculated for [C14H20N2S]; [M+H]+: m/z 249.1425, found m/z 249.1429.
4-(phenylmethyl)-1-propyl-2-piperazinethione (7);
1H NMR (400 MHz, CDCl3): d (ppm) 0.92–1.00 (t, 3H), 1.66–1.84 (m, 2H), 2.67–
2.78 (t, 2H), 3.42–3.49 (t, 2H), 3.52–3.56 (s, 2H), 3.66–3.73 (s, 2H), 3.82–3.93 (m,
2H), 7.12–7.50 (m, 5H).
HRMS calculated for [C14H20N2S]; [M+H]+: m/z 249.1425, found m/z 249.1429.
N-Methyl-2-methyl(phenylmethyl)amino]ethanethioamide (11);
1H NMR (500 MHz, DMSO-d6): d (ppm) 2.11–2.17 (s, 3H), 3.03–3.06 (d, 3H),
3.35–3.38 (s, 2H), 3.53–3.57 (s, 2H), 7.23–7.29 (t, 1H), 7.30–7.36 (t, 2H), 7.37–
7.42 (d, 2H), 9.69–9.95 (brs, 1H). 13C NMR (100 MHz, DMSO-d6): d (ppm) 30.5,
41.8, 60.9, 67.2, 126.6, 128.1, 129.0, 138.2, 199.3.
3. (a) Bobeck, D. R.; Lee, Hyoung I.; Flick, A. C.; Padwa, A. J. Org. Chem. 2009, 74,
7389–7402; (b) Kurasaki, H.; Okamoto, I.; Morita, N.; Tamura, O. Org. Lett. 2009,
11, 1179–1181.
4. (a) Ozaki, F.; Soejima, M.; Ishida, T.; Norimine, Y.; Kurusu, N.; Doi, E.; Kaneko, T.;
Hasegawa, D.; Kobayashi, K.; Yamamoto, N. WO200910191 PCT Int. Appl., 2009.;
(b) Blagg, J.; Fray, M. J.; Lewis, M. L.; Mathias, J. P.; Stefaniak, M. H.; Stobie, A.
WO2003076427 PCT Int. Appl., 2003.; (c) Qiao, J. X.; King, S. R.; He, K.; Wong, P.
C.; Rendina, A. R.; Luettgen, J. M.; Xin, B.; Knabb, R. M.; Wexler, R. R.; Lam, P. Y. S.
Bioorg. Med. Chem. Lett. 2009, 19, 462–468; (d) Martyn, D. C.; Cortese, J. F.;
Tyndall, E.; Dick, J.; Mazitschek, R.; Munoz, B.; Clardy, J. Bioorg. Med. Chem. Lett.
2010, 20, 218–221; (e) Carra, R. J.; Epperson, M. T.; Gin, D. Y. Tetrahedron 2008,
64, 3629–3641; (f) Jesberger, M.; Davis, T. P.; Barner, L. Synthesis 2003, 1929–
1958; (g) Kvasnica, M.; Rudovska, I.; Cisarova, I.; Sarek, J. Tetrahedron 2008, 64,
3736–3743; (h) Liang, X.; Fan, J.; Shi, F.; Su, W. Tetrahedron Lett. 2010, 51, 2505–
2507; (i) Shibahara, F.; Sugiura, R.; Murai, T. Org. Lett. 2009, 11, 3064–3067; (l)
Hansen, M. M.; Borders, S. S. K.; Clayton, M. T.; Heath, P. C.; Kolis, S. P.; Larsen, S.
D.; Linder, R. J.; Reutzel-Edens, S. M.; Smith, J. C.; Tameze, S. L.; Ward, J. A.;
Weigel, L. O. Org. Process Res. Dev. 2009, 13, 198–208; (m) Ozturk, T.; Ertas, E.;
HRMS calculated for [C11H16N2S]; [M+H]+: m/z 209.1112, found m/z 209.1110.
N-Methyl-2-(methylamino)-N-(phenylmethyl) ethanethioamide (12);
1H NMR (500 MHz, DMSO-d6): d (ppm) 2.32–2.38 (s, 3H), 3.21–3.24 (s, 3H),
3.64–3.69 (m, 2H), 5.27–5.31 (s, 2H), 3.52–3.56 (s, 2H), 3.66–3.73 (s, 2H), 3.82–
3.93 (m, 2H), 7.24–7.47 (m, 5H)
HRMS calculated for [C11H16N2S]; [M+H]+: m/z 209.1112, found m/z 209.1109.
1,4-bis(phenylmethyl)-2-piperazinethione-3-13C (17(13C)) and 1,4-bis(phenylmethyl)-
2-piperazinethione-2-13C (18(13C));
1H NMR (400 MHz, CDCl3): d (ppm) 2.64–2.84 (m, 4H), 3.35–3.46 (t, 4H), 3.53–3.62
(t, 4H), 3.63–4.03 (d, 2H), 3.80–3.85 (d, 2H), 5.24–5.38 (t, 4H), 7.29–7.41 (m, 20H).
13C NMR (100 MHz, CDCl3): d (ppm) 48.86, 48.87, 49.30, 56.47, 61.05, 61.07, 61.09,
64.81, 127.61, 127.98, 128.18, 128.51, 128.85, 129.08, 135.01, 136.57, 196.68.
HRMS calculated for [13CC17H20N2S]; [M+H]+: m/z 298.1459, found m/z 298.1455.